Company page
Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. is a public company traded under the ticker ZNTL in the American market. The company has a market capitalization of approximately $347.4 million. Zentalis focuses on developing innovative therapies for cancer treatment.
- Ticker
- ZNTL:NASDAQ
- Asset type
- Stock
- Market cap
- $332.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD